WMSA
NVRO

Weiss Multi-Strategy Advisers’s NEVRO CORP. NVRO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,400
Closed -$297K – 567
2015
Q4 		$297K Buy
+4,400
New +$236K 0.02% 334

Other funds holding NVRO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Weiss Multi-Strategy Advisers's NVRO Position: Q2 2019 in Review

Weiss Multi-Strategy Advisers sold out of NEVRO CORP. (NVRO) in Q2 2019, closing a stake of 15,000 shares — an estimated $938K sold.

Weiss Multi-Strategy Advisers first reported a position in NVRO in Q4 2015 and held it in 12 quarters. The position peaked at $4.09M in Q3 2017. 162 funds tracked by Wall St. Rank hold NVRO as of Q2 2019.

  • Weiss Multi-Strategy Advisers reported no remaining NEVRO CORP. position as of Q2 2019 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 15,000 NEVRO CORP. shares in Q2 2019, an estimated $938K.
  • Weiss Multi-Strategy Advisers first reported a position in NEVRO CORP. in Q4 2015 and held it in 12 quarters.
  • Weiss Multi-Strategy Advisers's NEVRO CORP. position peaked at $4.09M in Q3 2017.
  • 162 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2019.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.